ATE227717T1 - 3-pyridylenantiomere und ihre verwendung als analgetika - Google Patents
3-pyridylenantiomere und ihre verwendung als analgetikaInfo
- Publication number
- ATE227717T1 ATE227717T1 AT97952392T AT97952392T ATE227717T1 AT E227717 T1 ATE227717 T1 AT E227717T1 AT 97952392 T AT97952392 T AT 97952392T AT 97952392 T AT97952392 T AT 97952392T AT E227717 T1 ATE227717 T1 AT E227717T1
- Authority
- AT
- Austria
- Prior art keywords
- analgesics
- antiomers
- pyridylene
- formula
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3232196P | 1996-12-10 | 1996-12-10 | |
US76327896A | 1996-12-10 | 1996-12-10 | |
PCT/US1997/022811 WO1998025920A1 (en) | 1996-12-10 | 1997-12-10 | 3-pyridyl enantiomers and their use as analgesics |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE227717T1 true ATE227717T1 (de) | 2002-11-15 |
Family
ID=26708255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97952392T ATE227717T1 (de) | 1996-12-10 | 1997-12-10 | 3-pyridylenantiomere und ihre verwendung als analgetika |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0950057B1 (de) |
JP (2) | JP4272261B2 (de) |
KR (2) | KR100422995B1 (de) |
CN (1) | CN1125064C (de) |
AT (1) | ATE227717T1 (de) |
AU (1) | AU733881B2 (de) |
BG (1) | BG64196B1 (de) |
BR (1) | BR9714677A (de) |
CA (2) | CA2273917C (de) |
DE (1) | DE69717148T2 (de) |
DK (1) | DK0950057T3 (de) |
ES (1) | ES2189003T3 (de) |
HU (1) | HUP0001110A3 (de) |
IL (1) | IL130083A0 (de) |
NO (1) | NO992705L (de) |
NZ (1) | NZ335810A (de) |
PL (1) | PL333920A1 (de) |
PT (1) | PT950057E (de) |
SK (1) | SK75999A3 (de) |
TR (1) | TR199901904T2 (de) |
WO (1) | WO1998025920A1 (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002510619A (ja) | 1998-04-02 | 2002-04-09 | アール・ジェイ・レイノルズ・タバコ・カンパニー | 薬剤組成物及びその使用法 |
US6054451A (en) * | 1998-04-21 | 2000-04-25 | Algos Pharmaceutical Corporation | Analgesic composition and method for alleviating pain |
US6541669B1 (en) | 1998-06-08 | 2003-04-01 | Theravance, Inc. | β2-adrenergic receptor agonists |
US20010031771A1 (en) | 1999-05-24 | 2001-10-18 | Gary Maurice Dull | Pharmaceutical compositions and methods for use |
US6103911A (en) * | 1999-06-15 | 2000-08-15 | Abbott Laboratories | Process for reduction of (2R)-4-oxoazetidinone-2-carboxylic acid |
US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
JP2006504634A (ja) * | 2002-05-15 | 2006-02-09 | アボット・ラボラトリーズ | 神経障害性疼痛の治療 |
EP1741709A1 (de) | 2005-06-28 | 2007-01-10 | Sanofi-Aventis Deutschland GmbH | Heteroaryl substituierte Amide mit gesättigtem Linker, und deren Verwendung als Pharmaka |
CA2631128A1 (en) | 2005-12-09 | 2007-06-14 | F. Hoffmann-La Roche Ag | Tricyclic amide derivatives useful for treating obesity |
TW200800020A (en) * | 2006-01-26 | 2008-01-01 | Basf Ag | Methods to use 3-pyridyl derivatives as pesticides |
WO2008028903A2 (en) | 2006-09-04 | 2008-03-13 | Neurosearch A/S | Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer |
JP4939192B2 (ja) * | 2006-12-05 | 2012-05-23 | ユニ・チャーム株式会社 | 不織布、不織布の製造方法及び吸収性物品 |
DE102007058504A1 (de) | 2007-12-05 | 2009-07-09 | Acino Ag | Transdermales therapeutisches System mit einem Gehalt an einem Modulator für nikotinische Acetylcholinrezeptoren (nAChR) |
CN102216289A (zh) | 2008-10-14 | 2011-10-12 | 塞扣吉尼克斯公司 | 烟碱乙酰胆碱受体配体及其用途 |
US8474529B2 (en) * | 2009-04-09 | 2013-07-02 | Regency Technologies Llc | Control of concentric tubing direction |
AR075988A1 (es) * | 2009-04-09 | 2011-05-11 | Lilly Co Eli | Compuesto de piridiloxi - pirrolidina inhibidor de recaptacion de serotonina y norepinefrina, composicion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de dolor cronico |
RU2014103098A (ru) | 2011-06-30 | 2015-08-10 | Торэй Индастриз, Инк. | Противозудный агент |
CA2944179A1 (en) * | 2013-03-27 | 2014-10-02 | Georgetown University | 2-halo-5-alkynyl-pyridyl nicotinic ligands |
CA3066361A1 (en) | 2017-06-07 | 2018-12-13 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
US11511103B2 (en) | 2017-11-13 | 2022-11-29 | Shifamed Holdings, Llc | Intravascular fluid movement devices, systems, and methods of use |
CN112004563B (zh) | 2018-02-01 | 2024-08-06 | 施菲姆德控股有限责任公司 | 血管内血泵以及使用和制造方法 |
WO2021011473A1 (en) | 2019-07-12 | 2021-01-21 | Shifamed Holdings, Llc | Intravascular blood pumps and methods of manufacture and use |
WO2021016372A1 (en) | 2019-07-22 | 2021-01-28 | Shifamed Holdings, Llc | Intravascular blood pumps with struts and methods of use and manufacture |
US11724089B2 (en) | 2019-09-25 | 2023-08-15 | Shifamed Holdings, Llc | Intravascular blood pump systems and methods of use and control thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8301702D0 (en) * | 1983-01-21 | 1983-02-23 | Shell Int Research | Azetidine compounds |
US4902684A (en) * | 1988-06-20 | 1990-02-20 | E. R. Squibb & Sons, Inc. | Benzazepine and benzothiazepine derivatives |
US5068234A (en) * | 1990-02-26 | 1991-11-26 | Sterling Drug Inc. | 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles |
IL107184A (en) * | 1992-10-09 | 1997-08-14 | Abbott Lab | Heterocyclic ether compounds that enhance cognitive function |
US5585388A (en) * | 1995-04-07 | 1996-12-17 | Sibia Neurosciences, Inc. | Substituted pyridines useful as modulators of acetylcholine receptors |
IL118279A (en) * | 1995-06-07 | 2006-10-05 | Abbott Lab | Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission |
US5629325A (en) * | 1996-06-06 | 1997-05-13 | Abbott Laboratories | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
-
1997
- 1997-12-10 HU HU0001110A patent/HUP0001110A3/hu unknown
- 1997-12-10 TR TR1999/01904T patent/TR199901904T2/xx unknown
- 1997-12-10 CA CA2273917A patent/CA2273917C/en not_active Expired - Fee Related
- 1997-12-10 PL PL97333920A patent/PL333920A1/xx unknown
- 1997-12-10 CA CA2698384A patent/CA2698384C/en not_active Expired - Fee Related
- 1997-12-10 CN CN97181628A patent/CN1125064C/zh not_active Expired - Fee Related
- 1997-12-10 JP JP52698398A patent/JP4272261B2/ja not_active Expired - Fee Related
- 1997-12-10 PT PT97952392T patent/PT950057E/pt unknown
- 1997-12-10 SK SK759-99A patent/SK75999A3/sk unknown
- 1997-12-10 KR KR10-1999-7005151A patent/KR100422995B1/ko not_active IP Right Cessation
- 1997-12-10 WO PCT/US1997/022811 patent/WO1998025920A1/en not_active Application Discontinuation
- 1997-12-10 AU AU56010/98A patent/AU733881B2/en not_active Ceased
- 1997-12-10 AT AT97952392T patent/ATE227717T1/de active
- 1997-12-10 DE DE69717148T patent/DE69717148T2/de not_active Expired - Lifetime
- 1997-12-10 KR KR10-2003-7008788A patent/KR100472154B1/ko not_active IP Right Cessation
- 1997-12-10 BR BR9714677-3A patent/BR9714677A/pt not_active IP Right Cessation
- 1997-12-10 ES ES97952392T patent/ES2189003T3/es not_active Expired - Lifetime
- 1997-12-10 EP EP97952392A patent/EP0950057B1/de not_active Expired - Lifetime
- 1997-12-10 IL IL13008397A patent/IL130083A0/xx unknown
- 1997-12-10 NZ NZ335810A patent/NZ335810A/en unknown
- 1997-12-10 DK DK97952392T patent/DK0950057T3/da active
-
1999
- 1999-06-03 NO NO992705A patent/NO992705L/no not_active Application Discontinuation
- 1999-07-06 BG BG103556A patent/BG64196B1/bg unknown
-
2008
- 2008-12-24 JP JP2008327771A patent/JP5364872B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE227717T1 (de) | 3-pyridylenantiomere und ihre verwendung als analgetika | |
NL300382I1 (nl) | Treatment of pompe's disease | |
EA200000723A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
BRPI0408784A (pt) | método para usar um composto | |
SE9604786D0 (sv) | New compounds | |
IL173032A0 (en) | Pyridazine derivatives and their use as therapeutic agents | |
DE59509846D1 (de) | [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE | |
DE69735442D1 (de) | Antidiabetische mittel | |
DE69814394D1 (de) | Verwendung von levobupivacain | |
FI964771A0 (fi) | (a)-annelloidut pyrrolijohdannaiset ja niiden käyttö farmasiassa | |
ES2179063T3 (es) | Procedimientos para tratar neoplasmas resistentes. | |
CA2289017A1 (en) | The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer | |
NO991734L (no) | Pyrazolinoner for behandling av potensforstyrrelser | |
EE9800315A (et) | Meetod südamepuudulikkuse käitlemiseks endoteliini antagonistide abil | |
IT1288399B1 (it) | Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi | |
GR3032224T3 (en) | Therapeutic agent for threatened abortion. | |
ES2154290T3 (es) | Estimulacion de la diferenciacion celular por sindecano. | |
DK0617023T3 (da) | Benzimidazolderivater, deres fremstilling og anvendelse | |
ES2159087T3 (es) | Oxindoles sustituidos con adamantilo como agentes farmaceuticos. | |
MX9701528A (es) | Derivados de 1, 1, 2,- trifenilbut-1-eno para tratar la enfermedad de alzheimer. | |
YU34693A (sh) | Polipeptidi blokatori prolaza kalcijuma | |
PE61999A1 (es) | Compuestos de tetrahidropiridina | |
TH32887A (th) | สารประกอบทางเคมี |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0950057 Country of ref document: EP |